BWL
TXG icon

Bogart Wealth LLC’s 10x Genomics TXG Stock Holding History

Bogart Wealth LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652 Hold
17
– – ﹤0.01% 1712
2026
Q1 		$361 Buy
+17
New +$340 ﹤0.01% 1654
2023
Q1 		– Sell
-15
Closed -$547 – 1207
2022
Q4 		$547 Hold
15
– – ﹤0.01% 909
2022
Q3 		$0 Sell
15
-8
-35% -$305 ﹤0.01% 1140
2022
Q2 		$1K Buy
23
+8
+53% +$415 ﹤0.01% 873
2022
Q1 		$1K Hold
15
– – ﹤0.01% 766
2021
Q4 		$2K Hold
15
– – ﹤0.01% 675
2021
Q3 		$2K Buy
+15
New +$2.58K ﹤0.01% 653

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bogart Wealth LLC's TXG Position: Q2 2026 in Review

Bogart Wealth LLC held its 10x Genomics (TXG) position steady in Q2 2026 at 17 shares worth $652. The position accounts for ﹤0.01% of the portfolio, ranked #1712.

Bogart Wealth LLC first reported a position in TXG in Q3 2021 and has held it in 8 quarters since. The position peaked at $2K in Q4 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Bogart Wealth LLC held 17 shares of 10x Genomics worth $652 as of Q2 2026.
  • Bogart Wealth LLC left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1712 holding.
  • Bogart Wealth LLC first reported a position in 10x Genomics in Q3 2021 and has held it in 8 quarters since.
  • Bogart Wealth LLC's 10x Genomics position peaked at $2K in Q4 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.